Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 11/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 11/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.31 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.31 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.31 |
| ▸ | FAAH | O00519 | 3/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22610051 | 0.95 | LPAR3 (0.42) | LPAR3LPAR2LPAR1TSHRALDH1A1 | |
| Phosphoric Acid SCHEMBL28328622 | 0.87 | LPAR3 (0.36) | LPAR3LPAR2LPAR1TSHRALDH1A1 | |
| SCHEMBL5173930 | 0.87 | LPAR3 (0.46) | LPAR3LPAR2LPAR1TSHRALDH1A1 | |
| SCHEMBL28221577 | 0.85 | LPAR3 (0.49) | LPAR3LPAR2LPAR1TSHRALDH1A1 | |
| SCHEMBL28298724 | 0.82 | TSHR (0.36) | LPAR3LPAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL5174987 | 0.82 | LPAR3 (0.44) | LPAR3LPAR2LPAR1TSHRALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL28190671 | 0.81 | LPAR3 (0.42) | LPAR3LPAR2LPAR1TSHRALDH1A1 | |
| SCHEMBL28189957 | 0.81 | LPAR3 (0.42) | LPAR3LPAR2LPAR1TSHRALDH1A1 | |
| SCHEMBL6557557 | 0.81 | TSHR (0.45) | TSHRALDH1A1CYP3A4HPGDFAAH | |
| SCHEMBL19456974 | 0.81 | TSHR (0.45) | TSHRALDH1A1CYP3A4HPGDFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118338879-A | Curable composition for dental use | 可乐丽则武齿科株式会社 | 2024-07-12 | — | — | CN | disclosed |
| US-12011490-B2 | Dental photocurable composition excellent in operability and storage stability | SHOFU INC. (JP) | 2024-06-18 | — | — | US | disclosed |
| US-20240173211-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT KIT | SHOFU INC. (JP) | 2024-05-30 | — | — | US | disclosed |
| EP-3888616-B1 | DENTAL PHOTOCURABLE COMPOSITION EXCELLENT IN COLOR TONE SELECTIVITY | SHOFU INC (JP) | 2024-05-15 | — | — | EP | disclosed |
| EP-4321145-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT KIT | Shofu Inc. (JP) | 2024-02-14 | — | — | EP | disclosed |
| CN-112545900-B | Dental curable composition containing transition metal adsorbent | 株式会社松风 | 2024-02-13 | — | — | CN | disclosed |
| CN-113440418-B | Dental polymerizable composition | 株式会社GC | 2023-12-26 | — | — | CN | disclosed |
| CN-116916872-A | Dental composition | 可乐丽则武齿科株式会社 | 2023-10-20 | — | — | CN | disclosed |
| US-11696874-B2 | Dental photocurable composition excellent in color tone selectivity | SHOFU INC. (JP) | 2023-07-11 | — | — | US | disclosed |
| CN-111050731-B | Non-solvent dental adhesive composition | 可乐丽则武齿科株式会社 | 2023-06-20 | — | — | CN | disclosed |
| WO-2021049269-A1 | GLASS POWDER AND CHEMICAL POLYMERIZATION INITIATOR | 株式会社ジーシー | 2021-03-18 | — | — | WO | disclosed |
| WO-2021049268-A1 | POLYMERIZABLE DENTAL COMPOSITION | 株式会社ジーシー | 2021-03-18 | — | — | WO | disclosed |
| WO-2021049335-A1 | DENTAL POLYMERIZABLE COMPOSITION | 株式会社ジーシー | 2021-03-18 | — | — | WO | disclosed |
| US-20210000699-A1 | POWDER-LIQUID TYPE RESIN-REINFORCED DENTAL GLASS IONOMER CEMENT COMPOSITION | SHOFU INC. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20210000698-A1 | TWO-PASTE TYPE DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION | SHOFU INC. (JP) | 2021-01-07 | — | — | US | disclosed |
| EP-3733153-A1 | TWO-PASTE TYPE RESIN-REINFORCED DENTAL GLASS IONOMER CEMENT COMPOSITION | Shofu Inc. (JP) | 2020-11-04 | — | — | EP | disclosed |
| EP-3733152-A1 | POWDER-LIQUID TYPE RESIN-REINFORCED DENTAL GLASS IONOMER CEMENT COMPOSITION | Shofu Inc. (JP) | 2020-11-04 | — | — | EP | disclosed |
| WO-2020195026-A1 | DENTAL RESTORATIVE MATERIAL SET AND TOOTH RESTORATION METHOD | 株式会社ジーシー | 2020-10-01 | — | — | WO | disclosed |
| CN-111050731-A | Non-solvent adhesive composition for dental use | 可乐丽则武齿科株式会社 | 2020-04-21 | — | — | CN | disclosed |
| CN-110785159-A | Dual paste type dental curable composition | 可乐丽则武齿科株式会社 | 2020-02-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210000698-A1 | TWO-PASTE TYPE DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION | ARID2, TAS2R42, MMAB | LPAR3 4789/4885LPAR2 4736/4885LPAR1 4807/4885 |
| US-12011490-B2 | Dental photocurable composition excellent in operability and storage stability | H1-0, CCND1, CCNT1 | LPAR3 3842/4885LPAR2 4068/4885LPAR1 3024/4885 |
| US-11696874-B2 | Dental photocurable composition excellent in color tone selectivity | HBG1, MARK1, KATNA1 | LPAR3 4537/4885LPAR2 4496/4885LPAR1 3995/4885 |
| US-20240173211-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT KIT | GRIK1, GRIN2B, GRIK2 | LPAR3 4577/4885LPAR2 4592/4885LPAR1 4612/4885 |
| US-20210000699-A1 | POWDER-LIQUID TYPE RESIN-REINFORCED DENTAL GLASS IONOMER CEMENT COMPOSITION | WDR1, WDR91, WDR5 | LPAR3 4705/4885LPAR2 4820/4885LPAR1 4738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.